Business · 29/04/2024
FDA Announces Availability of Draft Guidance for Industry on Raw Data for Safety and Effectiveness Studies
The Food and Drug Administration (FDA) has released a draft guidance document (GFI #287) outlining the agency's recommendations for using raw data in the review of safety and effectiveness studies for new animal drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →